P

Inventor

FINBERG JOHN P M

IL20 patents
⚠️ This page may combine multiple inventors who share the name “FINBERG JOHN P M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEVA PHARMA

18 patents
US5891923AApr 6, 1999

R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia

TEVA PHARMA97 citations99
US5519061AMay 21, 1996

R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof

TEVA PHARMA139 citations99
US5457133AOct 10, 1995

R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them

TEVA PHARMA112 citations99
US6630514B2Oct 7, 2003

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMA77 citations98
US5786390AJul 28, 1998

Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan

TEVA PHARMA105 citations98
US5532415AJul 2, 1996

R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof

TEVA PHARMA169 citations98
US5744500AApr 28, 1998

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMA100 citations97
US5668181ASep 16, 1997

Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression

TEVA PHARMA92 citations97
US5599991AFeb 4, 1997

Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan

TEVA PHARMA84 citations97
US5576353ANov 19, 1996

Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds

TEVA PHARMA101 citations97
US5453446ASep 26, 1995

Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.

TEVA PHARMA104 citations97
US5387612AFeb 7, 1995

Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's disease

TEVA PHARMA114 citations97
US6528685B2Mar 4, 2003

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA47 citations96
US6277886B1Aug 21, 2001

Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan

TEVA PHARMA66 citations96
US5914349AJun 22, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA50 citations96
US5877221AMar 2, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA52 citations96
US5994408ANov 30, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA54 citations95
US5880159AMar 9, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA47 citations94

TECHNION RES & DEV FOUNDATION

2 patents